Degron Therapeutics
ID: 12996678Song biological aims to become the world's leading innovative protein degradation of drugs - molecular glue type of small molecule drug research and development company. Composed of world-class management and scientific leaders with international vision and rich industry experience dage team
1
Funding Rounds
$22.0m
Money raised
Recent Funding Rounds
Overview
- Website:
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Degron Therapeutics has raised a total of $22m in funding over 1 rounds.
Key Insights:
- Degron Therapeutics Series A round, June 2022: $22m